United Pharm Capital Reinvestment Ratio
United Pharm capital reinvestment ratio. United Pharm (033270) has a Capital Reinvestment Ratio of 0.11x as of June 2026, meaning it reinvests 0% of its operating cash flow (₩13.70 Billion) in capital expenditures (₩1.47 Billion). See 033270 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of United Pharm (2011–2025)
Capital reinvestment ratio of United Pharm from 2011 to 2025. This chart tracks United Pharm's Capital Reinvestment Ratio across 14 annual periods. See United Pharm (033270) flexibility index to measure the company's free cash flow as a share of total liabilities.
United Pharm Capital Reinvestment Ratio by Year (2011–2025)
United Pharm capital reinvestment ratio by year from 2011 to 2025. For the full cash flow conversion analysis, see United Pharm (033270) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.49x | ₩51.14 Billion | ₩25.14 Billion | ▼ -37.9% |
| 2024 | 0.79x | ₩26.79 Billion | ₩21.22 Billion | ▲ +25.9% |
| 2023 | 0.63x | ₩49.77 Billion | ₩31.31 Billion | ▲ +65.8% |
| 2022 | 0.38x | ₩63.78 Billion | ₩24.21 Billion | ▲ +30.8% |
| 2021 | 0.29x | ₩44.09 Billion | ₩12.79 Billion | ▼ -14.5% |
| 2020 | 0.34x | ₩36.96 Billion | ₩12.55 Billion | ▼ -34.5% |
| 2019 | 0.52x | ₩38.15 Billion | ₩19.76 Billion | ▲ +10.1% |
| 2018 | 0.47x | ₩36.86 Billion | ₩17.35 Billion | ▼ -52.8% |
| 2017 | 1.00x | ₩27.68 Billion | ₩27.59 Billion | ▲ +125.1% |
| 2016 | 0.44x | ₩30.02 Billion | ₩13.29 Billion | ▲ +17.3% |
| 2014 | 0.38x | ₩21.31 Billion | ₩8.05 Billion | ▼ -40.8% |
| 2013 | 0.64x | ₩18.97 Billion | ₩12.11 Billion | ▲ +14.8% |
| 2012 | 0.56x | ₩21.88 Billion | ₩12.16 Billion | ▲ +2.6% |
| 2011 | 0.54x | ₩27.62 Billion | ₩14.95 Billion | — |